UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000031584
Receipt No. R000035952
Scientific Title Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1-negative or weakly positive advanced non-small-cell lung cancer after disease progression on platinum-based therapy. (EMERALD study) (WJOG10317L)
Date of disclosure of the study information 2018/03/05
Last modified on 2019/09/06 09:09:52

No. Disposal Last modified on Item of update
1 Insert 2018/03/05 14:12:08
2 Update 2018/03/05 16:09:37 Key inclusion criteria
3 Update 2018/03/27 18:06:49 Anticipated trial start date
4 Update 2019/03/06 09:25:45 Recruitment status
5 Update 2019/09/06 09:09:52 Date of IRB
Last follow-up date


Contact us.